The Hatter Cardiovascular Institute recently hosted a series of medical educational meetings to discuss new developments in the management of diabetes & cardiovascular disease. Audiences included researchers, primary care physicians and specialists clinicians. An area of interest was the new therapeutic agents including SGLT2 inhibitors and GLP-1 analogues.
The 2 Horizon series of meetings addressed diabetes management from multi-disciplinary perspectives bringing together Nephrology, Cardiology and Diabetology for comprehensive discussions. One meeting was held specifically for an audience of Primary Care Physicians while a second was directed to Specialist Clinicians.
Recognising the importance of informing clinical trainees early in their careers, a newly created series of Hatter Institute Scientific Meetings was created to address this need. Therefor in a third meeting, Trainees (SpR’s) in the specialities of Nephrology, Diabetes and Cardiology were invited to attend and found the day both beneficial to their area of interest but also for the ability to network with their colleagues in other disciplines who they might not otherwise meet, stimulating future multi-disciplinary teams.
Feedback from the above meetings was very positive and will help to guide further meetings later this year. We are grateful that those attending found these workshops so informative. We strive to create engaging programmes to disseminate the latest developments to benefit working practice and knowledge amongst the medical community.
Feedback reports from each of the 3 meetings can be found below:
HATTER HORIZON MEETING FEEDBACK REPORT_CLINICIAN_DEC19
HATTER HORIZON MEETING FEEDBACK REPORT_GP__DEC19
HATTER SCIENTIFIC MEETING FEEDBACK REPORT_TRAINEE_JAN20
Dates for upcoming Horizon and Hatter Scientific Workshops will be announced shortly.